We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
Cap. Flow
-$7.49M
Cap. Flow %
-8.61%
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$3.18M
2
JPM icon
JPMorgan Chase
JPM
+$3.16M
3
GIS icon
General Mills
GIS
+$2.29M
4
GILD icon
Gilead Sciences
GILD
+$2.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$4.04M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$2.56M
4
IBB icon
iShares Biotechnology ETF
IBB
+$2.03M
5
HUM icon
Humana
HUM
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 45.93%
2 Miscellaneous 21.87%
3 Consumer Staples 14.06%
4 Consumer Discretionary 4.38%
5 Financials 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
301
Heron Therapeutics
HRTX
$65.3M
– –
-29,937
Closed -$516K
HRTX icon
302
PUT
Heron Therapeutics
HRTX
$65.3M
– –
-30,000
Closed -$41K
HSY icon
303
Hershey
HSY
$34.8B
– –
-200
Closed -$19.7K
HUM icon
304
Humana
HUM
$48.2B
– –
-9,300
Closed -$1.77M
IBB icon
305
iShares Biotechnology ETF
IBB
$10.6B
– –
-21,000
Closed -$2.03M
IBB icon
306
PUT
iShares Biotechnology ETF
IBB
$10.6B
– –
-45,000
Closed -$221K
IBM icon
307
CALL
IBM
IBM
$221B
– –
-15,062
Closed -$113K
IBM icon
308
IBM
IBM
$221B
– –
-4,106
Closed -$623K
IBM icon
309
PUT
IBM
IBM
$221B
– –
-35,564
Closed -$81K
INTC icon
310
CALL
Intel
INTC
$506B
– –
-30,400
Closed -$65K
INTC icon
311
PUT
Intel
INTC
$506B
– –
-50,400
Closed -$6K
IONS icon
312
CALL
Ionis Pharmaceuticals
IONS
$9.65B
– –
-60,000
Closed -$315K
JAZZ icon
313
CALL
Jazz Pharmaceuticals
JAZZ
$16B
– –
-25,100
Closed -$3K
JCI icon
314
CALL
Johnson Controls International
JCI
$87.8B
– –
-69,350
Closed -$341K
JCI icon
315
PUT
Johnson Controls International
JCI
$87.8B
– –
-37,050
Closed -$23K
KLAC icon
316
CALL
KLA
KLAC
$242B
– –
-7,000
Closed -$2K
KLAC icon
317
KLA
KLAC
$242B
– –
-50,170
Closed -$350K
KLAC icon
318
PUT
KLA
KLAC
$242B
– –
-65,000
Closed -$42K
KMI icon
319
CALL
Kinder Morgan
KMI
$69.9B
– –
-15,600
Closed -$2K
KSS icon
320
Kohl's
KSS
$2.2B
– –
-5,000
Closed -$219K
KSS icon
321
PUT
Kohl's
KSS
$2.2B
– –
-5,000
Closed -$3K
LGND icon
322
CALL
Ligand Pharmaceuticals
LGND
$5.69B
– –
-16,030
Closed -$31K
LLY icon
323
Eli Lilly
LLY
$1.02T
– –
-4,000
Closed -$298K
LRMR icon
324
CALL
Larimar Therapeutics
LRMR
$398M
– –
-3,542
Closed -$3K
LULU icon
325
CALL
lululemon athletica
LULU
$11.1B
– –
-30,500
Closed -$1K
11 12
13
14 15

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2016 Portfolio in Review

As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $7.49M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.

  • FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
  • FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
  • FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
  • FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
  • FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
  • FT Options opened 86 new positions and closed 202 in Q4 2016.
  • FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.